Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 3/20 | 0.66 |
| ▸ | RXRB | P28702 | 3/20 | 0.66 |
| ▸ | ACHE | P22303 | 3/20 | 0.65 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.54 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.54 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.54 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.54 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.52 |
| ▸ | RXRG | P48443 | 1/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19987946 | 0.98 | RXRA (0.64) | RXRARXRBACHENR1H4NR4A1 | |
| SCHEMBL1041916 | 0.88 | RXRA (0.56) | RXRARXRBACHENR4A1NR4A2 | |
| SCHEMBL29466781 | 0.88 | RXRA (0.56) | RXRARXRBACHENR4A1NR4A2 | |
| SCHEMBL2637669 | 0.86 | RXRA (0.54) | RXRARXRBACHENR4A1NR4A2 | |
| SCHEMBL29486118 | 0.86 | RXRA (0.54) | RXRARXRBACHENR4A1NR4A2 | |
| SCHEMBL28374573 | 0.84 | NR1H4 (0.59) | RXRARXRBACHENR1H4NR4A1 | |
| SCHEMBL3932481 | 0.84 | SRD5A2 (0.57) | RXRARXRBACHENR4A2MRGPRX4 | |
| SCHEMBL29408183 | 0.84 | SRD5A2 (0.57) | RXRARXRBACHENR4A2MRGPRX4 | |
| SCHEMBL12065518 | 0.84 | RXRA (0.53) | RXRARXRBACHENR4A1NR4A2 | |
| SCHEMBL1635891 | 0.84 | ESR1 (0.55) | RXRARXRBACHENR1H4NR4A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 547 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118459334-A | Method for separating p-tert-butylbenzoic acid and m-tert-butylbenzoic acid isomers | 德清乾精新材料科技有限公司 | 2024-08-09 | — | — | CN | claimed |
| CN-112852014-B | Asymmetric organic aromatic ligand metal salt nucleating agent and preparation method and application thereof | 华东理工大学 | 2022-03-15 | — | — | CN | claimed |
| CN-112852014-A | Asymmetric organic aromatic ligand metal salt nucleating agent and preparation method and application thereof | 华东理工大学 | 2021-05-28 | — | — | CN | claimed |
| CN-109836618-B | Modification method of aluminum oxide | 中国石油天然气股份有限公司 | 2021-03-30 | — | — | CN | claimed |
| EP-4745191-A1 | POLYVINYL CHLORIDE-BASED RESIN COMPOSITION, AND FILM PRODUCED THEREFROM | Riken Technos Corporation (JP) | 2026-05-20 | — | — | EP | disclosed |
| CN-122037013-A | Catalytic component, catalyst for olefin prepolymerization or polymerization, and method for olefin prepolymerization or polymerization | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20250305210-A1 | FIBER-TREATING AGENT | KAO CORPORATION (JP) | 2025-10-02 | — | — | US | disclosed |
| US-12383560-B2 | Compounds and uses thereof | FOGHORN THERAPEUTICS INC. (US) | 2025-08-12 | — | — | US | disclosed |
| US-12286509-B2 | Radiation curable compositions | ALLNEX BELGIUM S.A. (BE) | 2025-04-29 | — | — | US | disclosed |
| WO-2025079658-A1 | FIBER TREATMENT AGENT | 花王株式会社 | 2025-04-17 | — | — | WO | disclosed |
| EP-4528021-A1 | FIBER-TREATING AGENT | Kao Corporation (JP) | 2025-03-26 | — | — | EP | disclosed |
| WO-2025018141-A1 | POLYVINYL CHLORIDE-BASED RESIN COMPOSITION, AND FILM PRODUCED THEREFROM | リケンテクノス株式会社 | 2025-01-23 | — | — | WO | disclosed |
| EP-0507576-A1 | Polypropylene-based resin compositions | TOSOH CORPORATION (JP) | 1992-10-07 | — | — | EP | disclosed |
| US-5153342-A | Esterification of 2,2,4-trimethyl-1,3-pentanediol with (alkyl) benzoic acids using basic catalysts | HULS AMERICA INC. (US) | 1992-10-06 | — | — | US | disclosed |
| US-5039728-A | Floor and wall coverings; vinly chloride homo- and copolymers | HULS AMERICA INC. (US) | 1991-08-13 | — | — | US | disclosed |
| US-5006585-A | Hydroxy ester compounds, stain resistance, vinyl chloride polymers | HULS AMERICA INC. (US) | 1991-04-09 | — | — | US | disclosed |
| EP-0416822-A2 | Stain-resistant plasticizer compositions and method of making same | VELSICOL CHEMICAL CORPORATION (US) | 1991-03-13 | — | — | EP | disclosed |
| US-4332701-A | FOR COATINGS | DUNLOP LIMITED (GB) | 1982-06-01 | — | — | US | disclosed |
| US-4131677-A | Anti-inflammatory oxazolo [5,4-b]pyridines | MERCK & CO., INC. (US) | 1978-12-26 | — | — | US | disclosed |
| US-4038396-A | ANTIPYRETICS, ANALGESICS | MERCK & CO., INC. (US) | 1977-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12383560-B2 | Compounds and uses thereof | VHL, CLN6, TFEB | RXRA 163/4885RXRB 103/4885ACHE 4721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.